Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01982357 · ClinicalTrials.gov registry record

Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies

A clinical trial of Infant, Premature, Diseases, sponsored by University of California, Irvine.

Completed
Registry status
32
Enrollment target
1
Study location

NCT01982357 is a study of Infant, Premature, Diseases that has completed, run by University of California, Irvine. The registered enrollment target is 32 participants, below the 203-participant average among 5 other Infant, Premature, Diseases trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01982357, a study of Infant, Premature, Diseases, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
32 participants
Enrollment target
1
Study location

Study Summary

Alterations to microvascular blood flow in premature infants, are known to contribute to several major disease entities. The optically-measured tissue blood flow, to determine tissue perfusion that can be use to detect blood loss.

Interventions

  • DEVICE Laser Speckle Imaging and Diffuse Optical Spectroscopy

Study Locations (1)

California

  • UCIMC - Orange

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2013-07-17
Est. Completion 2015-06-30

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT01982357

The ClinicalTrials.gov registry entry for NCT01982357 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 203-participant average among 5 other Infant, Premature, Diseases trials with a reported enrollment target (84% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infant, Premature, Diseases appearing as the primary indexed condition, and to 1 intervention - of which Laser Speckle Imaging and Diffuse Optical Spectroscopy is the first listed.

NCT01982357 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01982357 about?

NCT01982357 is a clinical study titled "Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies". Alterations to microvascular blood flow in premature infants, are known to contribute to several major disease entities. The optically-measured tissue blood flow, to determine tissue perfusion that can be use to detect blood loss.

What is the current status of trial NCT01982357?

This trial is currently completed. The enrollment target is 32 participants. The study started on 2013-07-17. Estimated completion is 2015-06-30.

What conditions does trial NCT01982357 study?

This clinical trial studies the following conditions: Infant, Premature, Diseases.

What interventions are being tested in trial NCT01982357?

The interventions under investigation include: Laser Speckle Imaging and Diffuse Optical Spectroscopy (DEVICE).

Who is sponsoring clinical trial NCT01982357?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01982357 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infant, Premature, Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.